Pfizer Limited (PFIZER)
Valuation Rating
Score: 10/100
Valuation Overview
| P/E Ratio | 35.50526 |
| P/B Ratio | 5.845838 |
| Dividend Yield | 0.70999996% |
| Current Price | ₹4792.5 |
| DCF Value | ₹1309.2418343509528 |
| Upside Potential | N/A% |
Intrinsic Values
| Current Price | ₹4792.5 |
| DCF Value | ₹1309.2418343509528 |
| Graham Value | ₹1687.2499999999998 |
| DDM Value | ₹505.0 |
| Earnings Value | ₹2860.9825131498815 |
| Average Value | ₹1457.3688631654222 |
Growth Confidence
| Revenue Growth | 0% |
| Earnings Growth | 0% |
| Revenue Confidence | 0% |
| Earnings Confidence | 0% |
| Margin Confidence | 0% |
| Overall Growth Confidence | 0% |
Growth Metrics
| EPS Growth | 6.3% |
| Revenue Growth | 2.3% |
| Market Cap | ₹21924.59 Cr |
Valuation Analysis Score: 10/100
Undervaluation Score: 10/100
Valuation Score: 10/30
Growth Score: 0/30
Intrinsic Value Score: 0/40
Growth Score: 0/30
Intrinsic Value Score: 0/40
Key Analysis Points:
- Excellent operating margins above 20%
Recommendation
Caution - Stock may be overvalued, detailed analysis recommended
Detailed Metrics
Current Price: ₹4,792.50
Operating Margins: 29.6%
Revenue Growth: 0.0%
Earnings Growth: 0.0%
Growth Confidence: 38.3%
Risk Assessment Guide
- Score 80-100: Significantly undervalued with strong fundamentals
- Score 60-79: Moderately undervalued with good potential
- Score 40-59: Fairly valued with balanced metrics
- Score Below 40: Potentially overvalued, exercise caution
Last Updated: 2025-01-23 06:37:31